MedPath

Multicenter Blood Culture Quality Improvement

Not Applicable
Completed
Conditions
Bacteremia
Interventions
Other: Blood Culture QI Program
Registration Number
NCT01413555
Lead Sponsor
Vanderbilt University
Brief Summary

False positive blood culture results due to specimen contamination with bacteria inhabiting patients' skin is a common problem in emergency departments (EDs) in the United States. Contaminated blood cultures lead to patient harm through unnecessary hospitalizations and ED visits, delays in surgery, unneeded antibiotics, and unnecessary procedures. The investigators have developed a multifaceted quality improvement improvement bundle (The Blood Culture QI Program) designed to minimize blood culture contamination in the ED. In this study, the investigators will implement the quality improvement bundle in six community hospital EDs and evaluate its effectiveness at reducing contamination.

Detailed Description

The Blood Culture QI Program has four components: (1) education: content knowledge and standardized experiential training on sterile technique designed for ED nurses; (2) process redesign: change in patient safety attitude and conversion of blood culture collection from a clean to a sterile technique; (3) checklist use: reinforcement of optimal blood culture collection technique at the point of care; (4) feedback: systematic charting and reporting of contamination rates to the ED nurses who collect cultures. In order to convert blood culture collection into a fully sterile procedure, the investigators developed the Sterile Blood Culture Collection Kit, a novel materials kit that contains the equipment needed to collect a culture using sterile technique, including: (1) a 3ml solution of 2% chlorhexidine gluconate - 70% isopropyl alcohol (Chloraprep, CareFusion) skin prep device; (2) a sterile drape; (3) a sterile needle; and (4) gauze.

The investigators will evaluate the effectiveness of the Blood Culture QI Program after implementing it in six community hospital EDs. Our study will compromise six replications of an interrupted time series study wherein each replication will be powered for internal validity to test the hypothesis of decreasing the contamination rate by 50% at each site. A stepped wedge (also called multiple baseline) design will be used to implement the program across hospitals to evaluate the generalizability (external validity) of program effectiveness. The primary analysis will be an interrupted time series analysis at each site comparing the proportion of ED blood cultures contaminated during a post-implementation intervention period with a pre-intervention baseline period.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
14889
Inclusion Criteria
  • Patients who have a blood culture ordered for clinical purposes in one of the participating centers during the study period.
Exclusion Criteria
  • Age < 18 years old

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Blood Culture QI ProgramBlood Culture QI Program-
Primary Outcome Measures
NameTimeMethod
Biweekly proportion of ED blood cultures contaminated1 year

In an interrupted time series design, we will compare the proportion of blood cultures contaminated during an intervention period after the implementation of the Blood Culture QI Program to a baseline period before implementation. We will complete six separate interrupted time series analyses with one at each of six hospitals. The intervention and baseline period duration will be approximately one year at each hospital.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Vanderbilt University Medical Center Emergency Medicine

🇺🇸

Nashville, Tennessee, United States

Vanderbilt Emergency Medicine

🇺🇸

Nashville, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath